Skip to main content

An In Vivo Model to Evaluate Donor-Dependent Cytokine Release

Dr. Kyle Draheim discusses developing a translational humanized mouse model for preclinical assessment of efficacy and CRS related to immuno-oncology therapies single agents and in combination.

Presented at the JAX Immunology Scientific Sessions, Dr. Kyle Draheim of The Jackson Laboratory describes her recent work developing a sensitive, translational humanized mouse model for preclinical assessment of efficacy and CRS related to immuno-oncology therapies as single agents and in combination.